Hydroxyphenylacetylglycine
CAS No. 28116-23-6
Hydroxyphenylacetylglycine( —— )
Catalog No. M33221 CAS No. 28116-23-6
Hydroxyphenylacetylglycine (p-Hydroxyphenylacetylglycine) is an endogenous human metabolite.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 29 | In Stock |
|
| 10MG | 37 | In Stock |
|
| 25MG | 65 | In Stock |
|
| 50MG | 105 | In Stock |
|
| 100MG | 154 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 392 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameHydroxyphenylacetylglycine
-
NoteResearch use only, not for human use.
-
Brief DescriptionHydroxyphenylacetylglycine (p-Hydroxyphenylacetylglycine) is an endogenous human metabolite.
-
DescriptionHydroxyphenylacetylglycine is an acyl glycine, and an endogenous human metabolite.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayProteasome/Ubiquitin
-
TargetEndogenous Metabolite
-
RecptorEndogenous Metabolite
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number28116-23-6
-
Formula Weight209.2
-
Molecular FormulaC10H11NO4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (478.01 mM; Ultrasonic )
-
SMILESC(C(NCC(O)=O)=O)C1=CC=C(O)C=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Glyceryl trimyristat...
Within the cell glyceryl trimyristate is primarily located in the membrane (predicted from logP) and adiposome. glyceryl trimyristate exists in all eukaryotes ranging from yeast to humans. In humans glyceryl trimyristate is involved in the metabolic disorder called de novo triacylglycerol biosynthesis glyceryl trimyristate pathway.
-
Carveol
(-)-Carveol, mixture of isomers is a monocyclic monoterpenic alcohol, present in essential oils of plant species such as Cymbopogon giganteus, Illicium pachyphyllum and in spices such as Carum carvi (cumin).
-
Cholesteryl oleate
Cholesteryl oleate is a cholesteryl ester. Cholesteryl oleate can be used to synthesize solid lipid nanoparticles which is a nanoparticle-based gene therapy approach.
Cart
sales@molnova.com